Cichocka-Jarosz Ewa, Brzyski Piotr, Jedynak-Wąsowicz Urszula, Nittner-Marszalska Marita
Department of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
"Dziupla" Statistical Analysis Piotr Brzyski, Krakow, Poland.
Postepy Dermatol Alergol. 2021 Apr;38(2):222-229. doi: 10.5114/ada.2021.106200. Epub 2021 May 22.
Hymenoptera venom allergy (HVA) is associated with a high risk of anaphylaxis. Effective treatment of HVA patients requires allergologists' familiarity with the latest HVA recommendations.
Evaluation of current practices in HVA diagnosis in Poland.
A survey questionnaire was conducted in 32 HVA centres in Poland.
The response rate was 97%. There were 1829 patients evaluated due to HVA in 2015. Sixty six percent ( = 21) of the centres used skin prick tests, out which 90% ( = 19) used 100 µg/ml of the venom extract as the highest concentration. All the centres performed intradermal tests (IDT) and serum specific IgE (sIgE), an initial diagnostic tool in 91% ( = 29). The highest venom concentration in IDT was 1 µg/ml in 75% ( = 24), 0.1 µg/ml in 16% ( = 5), 0.01 µg/ml in 3% ( = 1) and 10 µg/ml in 6% ( = 2). Baseline serum tryptase was assessed in 84% of the centres ( = 27), out of which 53% ( = 17) tested all their patients, whereas 31% ( = 10) checked only those with life-threatening reactions. In case of negative IDT/sIgE, 59% of the centres ( = 19) performed components evaluation, while 19% ( = 6) did the basophil activation test. In case of no identification of the culprit insect and sensitization to both venoms, VIT employed venom with higher sIgE.
Most allergology centres in Poland follow HVA guidelines. We identified two inaccuracies in their HVA management including non-adequate venom concentration in IDT and a false belief in correspondence between sIgE concentration and severity of allergic reactions.
膜翅目昆虫毒液过敏(HVA)与严重过敏反应的高风险相关。对HVA患者进行有效治疗需要过敏症专科医生熟悉最新的HVA诊疗建议。
评估波兰HVA诊断的当前实践情况。
对波兰32个HVA中心进行了问卷调查。
回复率为97%。2015年因HVA接受评估的患者有1829例。66%(=21)的中心使用皮肤点刺试验,其中90%(=19)使用100μg/ml的毒液提取物作为最高浓度。所有中心均进行皮内试验(IDT)和血清特异性IgE(sIgE)检测,91%(=29)的中心将其作为初始诊断工具。IDT中最高毒液浓度为1μg/ml的占75%(=24),0.1μg/ml的占16%(=5),0.01μg/ml的占3%(=1),10μg/ml的占6%(=2)。84%(=27)的中心评估了基线血清类胰蛋白酶,其中53%(=17)对所有患者进行检测,而31%(=10)仅检查有危及生命反应的患者。在IDT/sIgE结果为阴性的情况下,59%(=19)的中心进行组分评估,19%(=6)的中心进行嗜碱性粒细胞活化试验。在未识别出致病昆虫且对两种毒液均过敏的情况下,特异性免疫治疗(VIT)采用sIgE较高的毒液。
波兰大多数过敏症专科中心遵循HVA指南。我们在其HVA管理中发现了两个不准确之处,包括IDT中毒液浓度不足以及对sIgE浓度与过敏反应严重程度之间对应关系的错误认识。